do not combine glp-1 receptor agonists with dpp-4 inhibitors guideline Insights into the Roles of GLP-1, DPP-4, and SGLT2 at the Crossroads of Cardiovascular, Renal, and Metabolic Pathophysiology do not combine dpp-4 inhibitors

GLP-1RA interventions may reduce the incidence of recurrent AP, particularly SEMA and tirzepatide

Data Availability Statement No new data were created or analyzed in this study.

While there is mixed evidence regarding whether GLP-1RA increase risk for acute pancreatitis and they are associated with thyroid tumors in animals, prescribers should consider these possible adverse effects in patients at elevated risk for either outcome

Unfortunately, numerous psychotropic medications can increase weight and appetite due to a variety of mechanisms, including antihistaminergic effects, direct appetite-stimulating effects, and proclivities to cause insulin resistance

The second article considers problems, side-effects and reasons to avoid GLP-1 and GIP/GLP-1 RAs, while the third reviews their role in weight management